Work

Effectiveness of dupilumab vs omalizumab in patients with severe asthma – The EU-ADVANTAGE study

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa2171

Authors: Giorgio W Canonica, Arnaud Bourdin, J. Christian Virchow, Juby Jacob-Nara, Kinga Borsos, Richard H Stanford, Nami Pandit-Abid, Zhixiao Wang, Mena Soliman, Lynn Huynh, Sarah Kalia, Mei Sheng Duh, Wendy Cheng

Institutions: IRCCS Humanitas Research Hospital, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Centre Hospitalier Universitaire de Montpellier, Universitätsmedizin Rostock, University of Rostock, Regeneron (United States), Analysis Group (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404100724

Cites:

Cited by:

Related to: 10